Abstract submission

 

Deadline: 11 June 2018 (23.59 hrs CET)

 

ABSTRACT SUBMISSION IS NOW CLOSED.

 

GENERAL INSTRUCTIONS

Abstracts must be submitted on-line on the ESTRO website at: www.estro.org.
We highly recommend completing your submission early - otherwise authors may experience technical delay due to server overload.

For questions regarding the on-line submission process, please e-mail abstracts@estro.org.

REGULATIONS 

With the submission of an abstract for ‘ESTRO meets Asia’ conference, the corresponding (presenting) author:

• Accepts responsibility for the accuracy of the abstract and ascertains that all authors are aware of the content before submission 

• Accepts to be the contact person for all correspondence related to the abstract and to inform the co-authors about its status 

• Accepts to identify any financial interest in products or processes described in the abstract. This includes stock ownership, membership on any advisory boards, commercially sponsored research or any other substantial relationships 

• Certifies that the information to be reported is for exclusive presentation in the session to which the abstract will be assigned if accepted and that the information will not be presented as such at any commercially sponsored satellite symposia during the conference.

Further notes: 

• Please log in to the abstract submission site with the presenting author login details 

• Abstracts must be submitted and presented at the conference in English. The Scientific Committee reserves the right to reject an abstract written in poor English. 

• Abstracts will be anonymised before review to ensure fairness and eliminate possible bias. Therefore, it is strictly forbidden to include the authors’ names or institutions in the body of the abstracts.

ABSTRACT FORMAT 

• Topic category: choose the topic category that refers to the main subject of the abstract. The Scientific Committee reserves the right to re-categorise the abstract. 

• Keywords: You can enter up to three keywords of your choice. 

• Presentation preference: authors should indicate the presentation preference (oral, or no preference). Please note that the final decision on the presentation format rests with the Scientific Committee. 

• Title: abstract titles should be brief and reflect the content of the abstract. The title (maximum 100 characters) is important since it focuses attention (it is the “showcase” for the presentation). Do not use capital letters in the title except for words that are always capitalised and do not use non-standard abbreviations. 

• Body of the abstract: abstracts should be structured in such a way as to include (1) Purpose/Objective; (2) Material/methods; (3) Results; (4) Conclusion. 

• The on-line abstract submission procedure: the on-line abstract submission system will not accept abstracts that exceed 3,000 characters (body of the abstract, including spaces). 

• The use of standard abbreviations is desirable. A special or unusual abbreviation must be placed (in round brackets) after the first appearance of the word for which it stands. 

• Table and image: with their submission authors may include maximum two (2) uploads (tables or images) in JPG, PNG or TIFF formats. These uploads are not included in the number of characters. The maximum pixel size of an image is 600(w) x 800 (h) pixel. 

• Data table: authors may include one data table using the insert table icon (we advise not to copy-paste a table into the body of the abstract). The characters in a data table are included in the overall number of characters allowed. 

• Equations: can be inserted in the text as images.

ABSTRACT SELECTION PROCESS 

Abstracts submitted for presentation will be reviewed by an international panel of experts in the field of the subject.

Abstract review criteria are based on clarity, supporting data, scientific rigour, potential significance, interest in the topic chosen and innovation or usefulness.

Work in progress: abstracts on research obviously not yet performed and results not yet obtained will be banned.

Encore abstracts: papers already presented in another meeting will not be considered, unless the previous audience is distinct from the ‘‘ESTRO meets Asia’ conference, congress audience (e.g. national meetings).

Abstracts will be selected for one of the following presentation formats: 

• Oral presentation: abstracts selected for oral presentation are presented at one of the proffered paper sessions in the programme. 

• Poster viewing: Standing next to their electronic poster, the presenting author will present their work in 5 minutes followed by 3 minutes for discussion led by chairpersons. 

• E-poster: abstracts selected as e-posters can be viewed in electronic format in special stations at the conference venue. 

Withdrawal of an abstract: abstracts submitted for ‘ESTRO meets Asia’ conference, can be withdrawn until 10 July 2018 (to withdraw your abstract you should send an email to abstracts@estro.org). After this date, withdrawal of abstracts is no longer possible. Abstracts selected for oral / poster presentation should be presented at the meeting. In case the first (presenting) author cannot attend the conference, he / she should assign a replacement and inform the ESTRO office of the replacement as soon as possible.

Notification of outcome of abstract submission will be sent by email by end July 2018.

ABSTRACT SUBMISSION TOPICS

CLINICAL
Head and neck
CNS
Haematology
Breast
Lung
Upper GI (oesophagus, stomach, pancreas, liver)
Lower GI (colon, rectum, anus)
Gynaecological (endometrium, cervix, vagina, vulva)
Prostate
Urology-non-prostate
Skin cancer/ malignant melanoma
Sarcoma
Paediatric tumours
Palliation
Elderly
Health services research / health economics
Communication

RADIOBIOLOGY
Radiobiology of normal tissues
Radiobiology of stem cells (cancer and normal tissue)
Radiobiology of particles and heavy ions
Radiation-induced signalling pathways
Tumour microenvironment
Immuno-radiobiology
Radiation and tumour metabolism
DNA damage response
Biological therapies (e.g. viruses, vaccines)
Radiation response biomarkers
Miscellaneous

PHYSICS
From 2D to IMRT: technology, treatment planning, delivery and QA
IGRT, patient positioning and mobilisation
Dosimetry, audits and risk assessment
Brachytherapy
Other

RTT
Positioning and immobilisation
Pre-treatment preparation
Treatment Delivery
Treatment verification
Patient information and support
Other

INTERDISCIPLINARY
Professional Education and training